CSLLY (CSLLY) Stock Price & Analysis
CSLLY (CSLLY) rose 2.11% to USD 17.44 as of June 9, 2026 at 23:47 UTC, according to Nexqual real-time market data.
CSLLY last closed at USD 17.08; the session ranged USD 17.18–17.6 on volume of 17,438 shares. Market capitalization is $33.41B, with a 52-week range of USD 16.29–44.86 (OQX). Source: Nexqual, June 9, 2026 at 23:47 UTC.
Key Statistics (as of June 9, 2026 at 23:47 UTC)
| Price | USD 17.44 |
|---|---|
| Change | ▲ 2.11% (up) |
| Previous Close | USD 17.08 |
| Open | USD 17.59 |
| Day Range | USD 17.18 – 17.6 |
| 52-Week Range | USD 16.29 – 44.86 |
| Volume | 17,438 shares |
| Market Cap | $33.41B |
| Exchange | OQX |
Technical Analysis (CSLLY)
Nexqual's technical model rates CSLLY "SELL" based on 1 bullish and 4 bearish signals across 124 daily candles, as of June 9, 2026 at 23:47 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 37.56 (neutral) |
| vs SMA50 | Below (USD 21.05) |
| MACD | -1.15 (negative) |
Analyst Ratings (CSLLY)
Wall Street analysts rate CSLLY "Hold" based on 1 analysts, with a mean price target of USD 25.54 (range USD 25.54–25.54), per Nexqual as of June 9, 2026 at 23:47 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 25.54 |
| High Target | USD 25.54 |
| Low Target | USD 25.54 |
| Buy / Hold / Sell | 0 / 1 / 0 |
Earnings (CSLLY)
Source: Nexqual, June 9, 2026 at 23:47 UTC.
Financials & Fundamentals (CSLLY)
| Total Revenue | $15.41B |
|---|---|
| Revenue Growth (YoY) | -1.80% |
| Gross Margin | +51.87% |
| Operating Margin | +31.65% |
| Profit Margin | +9.06% |
| ROE | +6.66% |
| Debt / Equity | 54.44 |
| Current Ratio | 2.57 |
| Total Cash | $1.14B |
| Total Debt | $11.14B |
| Free Cash Flow | $1.85B |
Source: Nexqual, June 9, 2026 at 23:47 UTC.
Financial Health Score (CSLLY)
Nexqual rates CSLLY's overall financial health "Solid" across five dimensions, as of June 9, 2026 at 23:47 UTC.
| Growth | Solid — Revenue +5% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 52%, operating 32% |
| Balance Sheet | Strong — $1.14B cash vs $11.1B debt |
| Cash Flow | Solid — FCF $1.85B, 12% margin |
| Efficiency | Mixed — ROE 7%, ROA 6.6% |
Ownership (CSLLY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.01% |
| Shares Outstanding | 1.92B |
| Float | 1.93B |
Source: Nexqual, June 9, 2026 at 23:47 UTC.
Leadership (CSLLY)
CSLLY is led by Gordon Naylor BEng (Hons), C.P.A., DipCompSc (age 62), CEO, MD & Director, per Nexqual as of June 9, 2026 at 23:47 UTC.
| CEO, MD & Director | Gordon Naylor BEng (Hons), C.P.A., DipCompSc (age 62) |
|---|---|
| Chief Financial Officer | Ken Lim (age 51) |
| Executive VP & COO | Mary Oates (age 62) |
| Senior Vice President of Research & Development Strategic Operations | Deirdre BeVard |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CMXHF | CSL Ltd. | USD 66 | ▼ 6.44% |
| IDEXY | Industria de Diseno Textil Indi | USD 16.07 | ▲ 2.23% |
| MKKGY | Merck KGaA | USD 32 | ▲ 2.11% |
| CHGCY | Chugai Pharmaceutical Co., Ltd. | USD 22.85 | ▼ 0.91% |
| AAGIY | AIA Group, Ltd. | USD 36.39 | ▼ 2.18% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 9, 2026 at 23:47 UTC. This page is informational and not investment advice.